MyHealthChecked PLC (GB:FORF)
LSE:FORF
Want to see GB:FORF full AI Analyst Report?
FORF Stock Chart & Stats
8.20 p
0.00 p(0.00%)
―
--
Day’s Range― - ―
52-Week Range6.00 p - 15.91 p
Previous CloseN/A
VolumeN/A
Average Volume (3M)35.18K
Market Cap
£2.65M
Enterprise Value-1.48M
Total Cash (Recent Filing)£5.06M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Sep 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding32,451,977
10 Day Avg. Volume35,100
30 Day Avg. Volume35,181
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)0.72
Price to Sales (P/S)0.00
P/FCF Ratio-2.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageThe balance sheet shows minimal debt and effectively zero debt-to-equity, giving the company low interest burden and financial flexibility. This conservatism provides runway and optionality to raise funds or restructure operations while working to restore revenue over the next months.
Proven Prior ProfitabilityHistorical profitability in 2021–2022 indicates the underlying business model can deliver positive margins at scale. That track record supports the view that, with restored demand or cost structure fixes, the company has operational playbooks and routes to return to profitability over a medium-term horizon.
Multi-channel DistributionOperating both in-house labs and direct-to-consumer plus B2B channels provides diversified go-to-market routes. Structurally this supports recurring demand, cross-sell between channels, and easier scale-up of at-home testing trends, improving resilience versus single-channel peers.
Bears Say
Severe Revenue CollapseA near-total revenue collapse destroys scale economics and long-term customer relationships. Loss of top-line revenue impairs fixed-cost absorption, pricing leverage and supplier terms, making multi-month recovery challenging and increasing execution risk to rebuild sustainable demand.
Negative Operating And Free Cash FlowSustained negative operating and free cash flow means the business is burning cash and reliant on reserves or financing. Over time this limits investment in labs, product development and commercial activity, raises dilution or debt risk, and shortens runway absent a clear cash-generating recovery.
Erosion Of Shareholder Equity And ReturnsDeclining equity and deeply negative returns signal value erosion from sustained losses. This reduces the balance-sheet buffer against future shocks, weakens counterparty confidence for contracts or partnerships, and constrains the firm's ability to pursue growth without dilutive capital.
MyHealthChecked PLC News
FORF FAQ
What was MyHealthChecked PLC’s price range in the past 12 months?
MyHealthChecked PLC lowest share price was 6.00 p and its highest was 15.91 p in the past 12 months.
What is MyHealthChecked PLC’s market cap?
MyHealthChecked PLC’s market cap is £2.65M.
When is MyHealthChecked PLC’s upcoming earnings report date?
MyHealthChecked PLC’s upcoming earnings report date is Sep 24, 2026 which is in 102 days.
How were MyHealthChecked PLC’s earnings last quarter?
Currently, no data Available
Is MyHealthChecked PLC overvalued?
According to Wall Street analysts MyHealthChecked PLC’s price is currently Undervalued.
Does MyHealthChecked PLC pay dividends?
MyHealthChecked PLC does not currently pay dividends.
What is MyHealthChecked PLC’s EPS estimate?
MyHealthChecked PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MyHealthChecked PLC have?
MyHealthChecked PLC has 32,451,977 shares outstanding.
What happened to MyHealthChecked PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MyHealthChecked PLC?
Currently, no hedge funds are holding shares in GB:FORF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MyHealthChecked PLC
Fortis Frontier PLC, headquartered in Cardiff, United Kingdom, specializes in the development, distribution, and commercialization of a diverse range of at-home health and well-being diagnostic kits across the UK market. The company provides a comprehensive portfolio of tests covering various health categories. For general well-being and energy, their offerings include blood profile assessments, along with rapid tests for detecting bowel health issues and stomach ulcers. Nutritional health is addressed through DNA tests for identifying intolerances and sensitivities, combined with blood and DNA-based analyses for vitamin and mineral levels, and quick checks for iron deficiency and vitamin D. Their weight management solutions encompass DNA and blood tests, glucose management DNA tests, and thorough thyroid function evaluations, including rapid tests for stimulating hormones. Additionally, Fortis Frontier provides specialized diagnostics for cardiovascular health (e.g., heart profile blood tests), women's health (featuring tests for female sexual health, Polycystic Ovary Syndrome, and menopause profiles), and men's health (with products for erectile dysfunction, male sexual health, and sperm concentration). Originally incorporated in 2008, the company was formerly known as MyHealthChecked PLC and is slated to officially adopt the name Fortis Frontier PLC in November 2025.
RUA Life Sciences
―
Creo Medical
―
EKF Diagnostics Holdings
―
Inspiration Healthcare
―
Surgical Innovations
―
Options Prices
Currently, No data available
---